Hot Features
Premium
Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 66,521 |
|
|||||
| News | - | ||||||
| Day High | 0.44 | Low High |
|||||
| Day Low | 0.4111 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Theriva Biologics Inc | TOVX | AMEX | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.038 | -8.48% | 0.41 | 17:19:02 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.4351 | 0.4111 | 0.44 | 0.4152 | 0.448 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 343 | 66,521 | US$ 0.4234414 | US$ 28,168 | - | 0.1972 - 1.20 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 19:00:00 | 365 | US$ 0.4152 | USD |
Theriva Biologics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 17.38M | 17.04M | - | 0 | -18.35M | -1.08 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Theriva Biologics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 2/07/2024 | 07:10 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/08/2024 | 07:10 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/15/2023 | 15:07 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 12/15/2023 | 15:01 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 12/15/2023 | 15:00 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 12/15/2023 | 15:00 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 11/13/2023 | 07:15 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 10/23/2023 | 06:10 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/17/2023 | 05:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/03/2023 | 05:06 | Edgar (US Regulatory) | Form 8-K - Current report |
| 8/16/2023 | 16:24 | Edgar (US Regulatory) | Form DEFR14A - Revised definitive proxy soliciting materials |
| 8/15/2023 | 08:53 | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TOVX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.45 | 0.46 | 0.4111 | 0.4413957 | 27,208 | -0.04 | -8.89% |
| 1 Month | 0.4801 | 0.5446 | 0.4111 | 0.4661006 | 53,437 | -0.0701 | -14.60% |
| 3 Months | 0.415 | 0.6845 | 0.41 | 0.5342167 | 99,927 | -0.005 | -1.20% |
| 6 Months | 0.485 | 0.6845 | 0.1972 | 0.5081309 | 77,640 | -0.075 | -15.46% |
| 1 Year | 0.71 | 1.20 | 0.1972 | 0.826347 | 231,252 | -0.30 | -42.25% |
| 3 Years | 0.80 | 1.26 | 0.1972 | 0.816938 | 176,604 | -0.39 | -48.75% |
| 5 Years | 0.80 | 1.26 | 0.1972 | 0.816938 | 176,604 | -0.39 | -48.75% |
Theriva Biologics Description
| Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11, leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. |
